NEOSTIGMINE METHYLSULFATE INJECTION, USP
JAMP PHARMA CORPORATION
Quick answers
Is there a shortage of NEOSTIGMINE METHYLSULFATE INJECTION, USP in Canada?
No. There is no current shortage of NEOSTIGMINE METHYLSULFATE INJECTION, USP 0.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
NEOSTIGMINE METHYLSULFATE INJECTION USP
SANDOZ CANADA INCORPORATED
PROSTIGMIN INJ 1:2000 USP
ICN CANADA LTD.
PROSTIGMIN INJ 1:1000 USP
ICN CANADA LTD.
NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP
DAVID BULL LABORATORIES (PTY) LTD.
NEOSTIGMINE METHYLSULFATE INJ 0.5MG/ML USP
DAVID BULL LABORATORIES (PTY) LTD.
PROSTIGMIN INJ 1:400 USP
ICN CANADA LTD.
DIN
02537516
Strength
0.5MG
Dosage Form
Solution
Route
Subcutaneous Intramuscular Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
2.5MG · DIN 02492199
10MG · DIN 02429225
5MG · DIN 02429217
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164